API

Eribulin Mesylate (1mg)

Drug classification

Click to see Drug classification

Dosage form

Click to see Dosage form

API strength per dosage

Click to see API strength per dosage

Dose

Click to see Dose

Mechanism of action

Click to see Mechanism of action

Indications

Metastatic breast cancer

Side effects

Anemia low number of red blood cells Weakness Hair loss Nausea Constipation Decreased white blood cell count Fatigue Peripheral neuropathy tingling and numbness of feet and hand

Pregnancy category

Click to see Pregnancy category

Precautions

Click to see Precautions

Contraindications

Click to see Contraindications